Thank You for Your Interest in BioXgen

You’re one step closer to owning a piece of BioXgen, advancing cardiac recovery with a patent-pending ECM-based patch designed to support patients after open-heart surgeries.

Step 1: Review Our Investor Brief

Learn how BioXgen’s patent-pending ECM-based cardiac patch is designed to support recovery after open-heart surgery, affecting up to 50% of patients and driving billions in related costs.

Download the Brief

Step 2: Ready to Become a Shareholder?

Visit our DealMaker campaign page to explore investment details, the clinical roadmap toward FDA clearance, offering terms, and the technology behind BioXgen’s mission to improve cardiac surgery recovery outcomes.

Invest on Dealmaker